Mintie ECU4 Corridor Flange assists with Surge Capacity during Pandemic

A recent Associate Press article states that California took 292 days to get to 1 million coronavirus infections, but only 44 days to top 2 million. Hospitals are stretched beyond normal capacity, causing some to treat patients in tents, offices, even auditoriums.

Healthcare facilities need to respond to potential circumstances of mass isolation surge capacity quickly and safely. Having a flexible solution to accommodate these unpredictable demands and needs is important, especially given the current, fixed infrastructures of many hospitals and care facilities.

A potential pandemic or large-scale outbreak of disease requires hospitals to establish areas of isolation where any virus can be fully contained using physical barriers and a negative pressure system to prevent airborne illnesses from spreading through heating, air conditioning and ventilation systems.

Mintie, LLC. is a worldwide leader in the manufacturing, distribution and deployment of environmental containment units (ECU), which allow the creation of collapsible, portable and modular containment units or temporary isolation spaces. The latest model, the ECU4, stores easily and can scale rapidly to accommodate large numbers of people or cover large areas including a hospital floor or wing with the addition of the corridor flange. The innovative design meets all ICRA containment requirement levels 1-4 and has been clinically tested and evaluated for efficacy of particle containment, ventilation and stability.

Contact Mintie for a contingency plan for pandemic surge capacity that will assist with mass isolation and further stop the surge of Covid-19 infections at hospitals.

Infection Prevention and Safety in Hospitals

Hospitals worldwide have faced many challenges during this pandemic, including strained resources as they worked tirelessly to control the spread of the virus and keep their patients and staff safe. With a vaccine approved and currently in distribution, we begin to see an end to a long and difficult time. While it will be many months before we have full distribution of the vaccine, we continue to learn what we can do better to prevent or slow the spread of highly contagious viruses, particularly within hospital settings.

Moving forward, hospitals and care facilities can review their current best practices in infection control and look for opportunities to develop, implement or upgrade strategies and protocols to provide the best possible protection for frontline workers and patients. Whether new construction, retrofits or other temporary and flexible solutions, investing in HVAC systems with appropriate components and infrastructure ensures maximum flexibility in handling the expected and unexpected. has an informative article, “5 Hospital HVAC Design Strategies for the Post-COVID-19 World,” to help facilitate discussions with a qualified indoor air quality management services company such as Mintie LLC on your HEPA filtration, air handling unit, negative pressure environment, and return air and exhaust air needs.

Mintie was founded in 1940 and has been a premiere leader in indoor air quality management services and product solutions development, portable infection control, mass isolation and environmental containment solutions. The company plays a national and increasingly international role in designing and developing innovative products and service solutions that work toward a safer, healthier and more productive environment for our clients.

Coronavirus Disease 2019 (COVID-19) – Information from the Centers for Disease Control and Prevention

What You Should You Know?

How COVID-19 Spreads?

The virus is thought to spread mainly from person-to-person.

  • Between people who are in close contact with one another (within about 6 feet).
  • Through respiratory droplets produced when an infected person coughs or sneezes.

These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.

Can someone spread the virus without being sick?

  • People are thought to be most contagious when they are most symptomatic (the sickest).
  • Some spread might be possible before people show symptoms; there have been reports of this occurring with this new coronavirus, but this is not thought to be the main way the virus spreads.

Spread from contact with infected surfaces or objects

It may be possible that a person can get COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes, but this is not thought to be the main way the virus spreads.

How easily the virus spreads

How easily a virus spreads from person-to-person can vary. Some viruses are highly contagious (spread easily), like measles, while other viruses do not spread as easily. Another factor is whether the spread is sustained, spreading continually without stopping.

The virus that causes COVID-19 seems to be spreading easily and sustainably in the community (“community spread”) in some affected geographic areas.

Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected.


Watch for Symptoms

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed coronavirus disease 2019 (COVID-19) cases.

The following symptoms may appear 2-14 days after exposure:

  • Fever
  • Cough
  • Shortness of breath

Call your doctor if you…

  • Develop symptoms, and have been in close contact with a person known to have COVID-19 OR
  • Have recently traveled from an area with widespread or ongoing community spread of COVID-19.

Prevention and Treatment


There is currently no vaccine to prevent coronavirus disease 2019 (COVID-19). The best way to prevent illness is to avoid being exposed to this virus. However, as a reminder, CDC always recommends everyday preventive actions to help prevent the spread of respiratory diseases, including:

  • Avoid close contact with people who are sick.
  • Avoid touching your eyes, nose, and mouth.
  • Stay home when you are sick.
  • Cover your cough or sneeze with a tissue, then throw the tissue in the trash.
  • Clean and disinfect frequently touched objects and surfaces using a regular household cleaning spray or wipe.
  • Follow CDC’s recommendations for using a facemask.
    • CDC does not recommend that people who are well wear a facemask to protect themselves from respiratory diseases, including COVID-19.
    • Facemasks should be used by people who show symptoms of COVID-19 to help prevent the spread of the disease to others. The use of facemasks is also crucial for health workers and people who are taking care of someone in close settings (at home or in a health care facility).
  • Wash your hands often with soap and water for at least 20 seconds, especially after going to the bathroom; before eating; and after blowing your nose, coughing, or sneezing.
    • If soap and water are not readily available, use an alcohol-based hand sanitizer with at least 60% alcohol. Always wash hands with soap and water if hands are visibly dirty.

For information about handwashing, see CDC’s Handwashing website.

For information specific to healthcare, see CDC’s Hand Hygiene in Healthcare Settings.

These are everyday habits that can help prevent the spread of several viruses. CDC does have specific guidance for travelers.


There is no specific antiviral treatment recommended for COVID-19. People with COVID-19 should receive supportive care to help relieve symptoms. For severe cases, treatment should include care to support vital organ functions.

People who think they may have been exposed to COVID-19 should contact their healthcare provider immediately.

See Interim Guidance for Healthcare Professionals for information on persons under investigation.


CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The test kit is called the “Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel.” It is intended for use with the Applied Biosystems 7500 Fast DX Real-Time PCR Instrument with SDS 1.4 software. This test is intended for use with upper and lower respiratory specimens collected from persons who meet CDC criteria for COVID-19 testing. CDC’s test kit is intended for use by laboratories designated by CDC as qualified, and in the United States, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. The test kits also will be shipped to qualified international laboratories, such as World Health Organization (WHO) Global Influenza Surveillance Response System (GISRS) laboratories. The test will not be available in U.S. hospitals or other primary care settings. The kits will be distributed through the International Reagent Resource (IRR).

On Monday, February 3, 2020, CDC submitted an Emergency Use Authorization (EUA) package to the U.S. Food and Drug Administration (FDA) in order to expedite FDA permitted use of the CDC diagnostic panel in the United States. The EUA process enables FDA to consider and authorize the use of unapproved, but potentially life-saving medical or diagnostic products during a public health emergency. The U.S. Secretary of Health and Human Services declared the SARS-CoV-2 virus a U.S. public health emergency on Friday, January 31, 2020. FDA issued the EUA on February 4, 2020. IRR began distribution of the test kits to states, but shortly thereafter performance issues were identified related to a problem in the manufacturing of one of the reagents which led to laboratories not being able to verify the test performance. CDC is remanufacturing the reagents with more robust quality control measures. New tests will be distributed once this issue has been addressed. CDC continues to perform initial and confirmatory testing.

Serology Test for COVID-19

CDC is working to develop a new laboratory test to assist with efforts to determine how much of the U.S. population has been exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

The serology test will look for the presence of antibodies, which are specific proteins made in response to infections. Antibodies can be found in the blood and in other tissues of those who are tested after infection. The antibodies detected by this test indicate that a person had an immune response to SARS-CoV-2, whether symptoms developed from infection or the infection was asymptomatic. Antibody test results are important in detecting infections with few or no symptoms.

Initial work to develop a serology test for SARS-CoV-2 is underway at CDC. In order to develop the test, CDC needs blood samples from people who had COVID-19 at least 21 days after their symptoms first started. Researchers are currently working to develop the basic parameters for the test, which will be refined as more samples become available. Once the test is developed, CDC will need additional samples to evaluate whether the test works as intended.

Mintie Announces Latest Generation of Fully Scalable Environmental Containment Units Designed to Prevent the Spread of Coronavirus (COVID-19) and Other Lethal Pathogens

LOS ANGELES, Calif. – February 18, 2020 – Mintie LLC, the global provider of indoor environmental systems, today announced the latest fully scalable Environmental Containment Unit (ECU) and mass isolation system designed to help prevent the spread of the deadly Coronavirus (2019-nCoV) and other respiratory and airborne illnesses.

The Mintie ECU4 provides temporary isolation in response to a surge of patients, or an escalation – and can scale rapidly to accommodate large numbers of people or cover large areas including a hospital floor or wing. The ECU4 is designed for fast, easy set-up and can be readily expanded or subdivided.

The new ECU4 has been clinically evaluated and rigorously tested for efficacy of particle containment, ventilation and stability in health care environments for Infection Control Risk Assessment (ICRA) containment requirement levels 1-4.

“In today’s highly connected world, viruses can travel faster and more readily than ever before and can occur in the most unexpected places,” said Kevin J. Mintie, President, Mintie LLC. “Facilities around the world need to be prepared for the latest outbreak and have the ability to contain the spread quickly and efficiently. The new Mintie ECU4 is designed to give transportation hubs, hospitals, schools, military facilities and other locations the preparedness they need to combat a pandemic or public health emergency.”

Scalability and flexibility are decisive qualities for emergency preparedness, since it is never possible to anticipate the size, scale or speed of a threat. The ECU4 solves the scalability issue with its modular design and expansion capabilities.

“When faced with a quickly unfolding public health emergency, flexibility is one of the most important factors in successful preparedness,” said James M. Mintie, Vice President of Products. “The modularity and scale of our ECU4 gives organizations the ability to isolate and quarantine patients, thus providing a scalable response to a rapidly evolving set of circumstances.”

The ECU4 is available now for delivery across the U.S. and around the world. Mintie also provides training, service and support. Other Mintie products and services include solutions for water intrusion remediation, infectious material containment, HVAC quality control, and more.

About Mintie

Founded in 1940, Mintie LLC began as specialty maintenance service company and has grown into a company with an international reputation for excellent service and innovative indoor environmental systems. Mintie provides indoor air quality management, preventative maintenance solutions and portable containment products for airborne particulates, infection control, and bio-security. Mintie has focused on leading the industry with innovative products and the highest quality services to provide clients with safer, healthier and more productive environments with minimal disruption and highest levels of satisfaction and effectiveness. The company serves a diverse mix of companies, ranging from market leaders to entrepreneurial start-ups within healthcare, biotechnology, entertainment, aerospace, manufacturing and commercial real estate. Mintie is an Alliance Environmental Group Company. For more information, visit

Information on the Coronavirus

(Links will open in a new window)

CDC Prevention & Treatment
Coronavirus Advice for Employers
Coronavirus Infections – More Than Just the Common Cold

Mintie ECU4 – The Next Generation of ECU Products


The new ECU4 is the next generation of the industry-leading ECU product line that redefines ease of use. The ECU4 features YKK #10 resin zippers, repositioned set up / release pins, upgraded internal operational springs, enhanced ball-bearing wheel assembly and wheels, double reinforced nylon floor, and reduced short side width to allow entrance to all patient rooms.

The modular ECU4 is a collapsible, portable containment unit or temporary isolation during normal facility operation or during a public health emergency. Designed to be a multi-functional containment solution to help organizations maximize their return on investment, the ECU4 combines the proven functionality of the ECU AnteRoom and Ceiling Cavity.

Download Mintie ECU4 Flyer

Alliance Environmental Group, LLC. Acquires Mintie Corporation

AZUSA, Calif. (PRWEB) April 08, 2019

Alliance Environmental Group, LLC announced today that it has acquired an interest in Mintie Corporation, a leading service and product solutions developer providing indoor air quality management, preventative maintenance, portable infection control, mass isolation and environmental containment solutions.

“We are excited to add the Mintie Corporation to our portfolio,” said Joseph McLean, Chief Executive Officer of Alliance Environmental. “They are a third generation, family-owned business and have a solid reputation as innovators in product development and quality services for healthcare and other sensitive environments, a company culture similar to ours, and a commitment to customer service that is in line with our business practices.”

Founded in 1940, Mintie began as a specialty maintenance service company and steadily built an international reputation for excellent service and innovative products.

“We are thrilled to be part of the Alliance Environmental family,” stated Kevin Mintie, President and Chief Executive Officer of Mintie. “We have exciting new products and services in development and believe Alliance is the right company to help us grow our business at both the national and international levels.”

Mintie Corporation will retain its brand identity and existing offices, expanding their market reach through existing Alliance Environmental offices and networks.

About Alliance Environmental Group, LLC:
With more than 75 years of experience, Alliance Environmental Group, LLC is one of the leading environmental contractors in California. Alliance Environmental provides innovative solutions in the areas of air and HVAC duct cleaning; asbestos, lead, and mold abatement; demolition and emergency response. The company has successfully completed more than 100,000 remediation projects ranging from bed bug elimination to residential mold removal in California and surrounding states. For more information, go to

About Mintie Corporation:
Los Angeles-based Mintie Corporation ( has been a leader in indoor air quality solutions to the healthcare, industrial and commercial sectors since 1940. With offices in the western United States Mintie professionals provide the highest quality HVAC system rehabilitation, cleaning and other services as well as preventative maintenance programs and emergency response. Mintie Technologies, a Mintie Corp. affiliate, is the market leader for designing and developing specialized containment products for airborne particulates, infection control, and bio-security and available internationally.